BUBU BANINI

Allopathic & Osteopathic Physicians|Internal Medicine NEW HAVEN, CT NPI 1427320985

General Payments — all program years on this page

$33,398.56

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 26
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $30,581.55 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $27,603.755
Travel and Lodging $2,210.508
Food and Beverage $767.3010

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $18,731.539
Boehringer Ingelheim Pharmaceuticals, Inc. $11,753.5813
Gilead Sciences, Inc. $96.441

By program year

Program yearAmountRecords
2019 $104.511
2023 $2,712.502
2024 $30,581.5523

Records — PY2024 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096577051 Novo Nordisk Inc $222.29 09/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096585205 Novo Nordisk Inc $441.64 09/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1096785089 Novo Nordisk Inc $1,550.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1096957399 Novo Nordisk Inc $2,712.50 05/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097093414 Novo Nordisk Inc $775.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097099886 Novo Nordisk Inc $550.70 09/19/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1097346194 Novo Nordisk Inc $148.67 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097398551 Novo Nordisk Inc $12,206.25 09/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1097672966 Novo Nordisk Inc $124.48 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005283 Boehringer Ingelheim Pharmaceuticals, Inc. $28.56 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005285 Boehringer Ingelheim Pharmaceuticals, Inc. $34.30 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005287 Boehringer Ingelheim Pharmaceuticals, Inc. $34.30 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005289 Boehringer Ingelheim Pharmaceuticals, Inc. $77.36 05/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118005291 Boehringer Ingelheim Pharmaceuticals, Inc. $81.15 05/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118005293 Boehringer Ingelheim Pharmaceuticals, Inc. $102.43 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005295 Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005297 Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 07/09/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118005299 Boehringer Ingelheim Pharmaceuticals, Inc. $190.87 05/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118005301 Boehringer Ingelheim Pharmaceuticals, Inc. $506.49 04/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1118005303 Boehringer Ingelheim Pharmaceuticals, Inc. $10,360.00 07/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1118005305 Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118005307 Boehringer Ingelheim Pharmaceuticals, Inc. $38.12 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133750860 Gilead Sciences, Inc. $96.44 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.